Since its inception in 1992 by Dr. Johannes Gassmueller, bioskin® has been recognized as a valuable partner for dermatological product development. Starting as a small Contract Research Organisation specialized in conducting early phase safety and efficacy trials in our clinical unit in Hamburg, bioskin® has grown into a full service CRO offering all core services for management of Phase I-IV drug trials and claim support / safety studies.
Headquartered in Hamburg, Germany, bioskin® added a second clinical unit in Germany’s capital and largest city, Berlin, in 2002 to expand recruitment capabilities for both patients with dermatological conditions and healthy volunteers. Further, bioskin® has established a network of dermatologists and university hospitals and has access to investigators across Europe and other parts of the world for the conduct of multinational studies in all dermatological indications. Later phase multicenter, multinational trials are managed by our project teams based in Hamburg.
Our global capabilities were boosted in 2009 by the formation of The International Dermatology Alliance in Clinical Research in cooperation with Cu-Tech, LLC, a leading US dermatology-only CRO, extending our reach into North America.